Original news and analysis on international IP policy
Nearly US$25,000 - and growing - in donations has been collected to hand over to Wikileaks if it successfully leaks the top-secret text of the Trans-Pacific Partnership (TPP) agreement currently under negotiation. The draft text has been blocked from public scrutiny while being shared only with industry.
For those who might be curious, the short answer is yes. For those who might be interested to learn more about the protection of geographical indications (GIs) in Russia, this article provides some insights into the Russian law that might be pertinent in light of Russia’s accession to the World Trade Organization and recent developments in the international GI law.
At least a dozen non-governmental groups from several continents have issued a joint statement opposing apparent copyright language proposed by the United States in the ongoing Trans-Pacific Partnership (TPP) agreement negotiations. The groups said the draft language, aimed at curbing copyright infringement, could undermine critical copyright exceptions, which are built into laws in order to protect society's access to public knowledge.
Gaudenz Silberschmidt, head of international affairs in Switzerland's public health office for the past decade, has been nominated to become senior adviser in the World Health Organization Office of the Director-General. He will have a special focus on the reform process taking place at the cash-strapped UN agency.
The Motion Picture Association of America (MPAA) today (29 August) issued a statement praising the platform language of the Republican Party, which is opposing President Obama in this year's presidential election.
A World Intellectual Property Organization project aimed at expanding research on diseases occurring predominately in developing countries using IP-protected material has announced its first research agreements.
The United States Justice Department and the National Federation of the Blind have reached a settlement with the Sacramento, California Public Library Authority to fix violations of the Americans with Disabilities Act caused by using Barnes & Noble NOOK electronic reader devices in a patron lending programme. The readers excluded persons who are blind or have other disabilities requiring features such as text-to-speech or access through audio or tactile options. The library will no longer purchase exclusionary devices and has agreed to acquire a set of accessible ones, as well as train staff on the requirements of the disabilities law.
Continuing the revolving door tradition between the United States government intellectual property and trade officials and the industries they represent, David Carson, general counsel of the US Copyright Office, will join the top international music industry association in September. Carson will assume a role of influencing policymakers in drafting legislation to protect and promote copyright. His is latest in a series of moves blurring US industry and government lines, and extending to the UN.
The Supreme Court of India today did not get to an agenda item involving a challenge to India's patent law by Swiss pharmaceutical company Novartis, and it is now scheduled to come up on 11 September. The case is considered to have potential widespread impact on the production of lower priced generic medicines.
A hearing in a case involving a challenge by Bayer pharmaceutical company of India's compulsory licence aimed at making a cancer drug more affordable is moved to 3 September, public health advocacy group Médecins Sans Frontières (MSF) announced today.
CAPE TOWN - South African health activists and pharmaceutical industry stakeholders are keeping close watch over the government's attempts to amend patent laws, which activists claim compromise the ability of the country's poor majority to access cheaper generic medicines.
The United States Court of Appeals for the Federal Circuit released a decision today (16 August) on the patentability of genes in yet another twist to the so-called Myriad case. At stake was the patentability of two human genes associated with hereditary breast cancer and ovarian cancer. Myriad Genetics' patents were challenged by the Association for Molecular Pathology.